Traditionally, lipids have been thought of as molecules that provide structure and energy, but their functional relevance in disease mechanisms is increasingly clear, and with advancements in mass spectrometry technologies, lipidomics analyses is a tool gaining recognition. Beyond the utility of lipoprotein and fatty acid profiles in clinical diagnosis and chemotaxonomic identifications, respectively, lipidomics analysis that combines knowledge across disciplines and can resolve exact lipid structures has the potential to advance clinical diagnoses and associated treatment, differentiate pathogen types (e.g., virus vs. bacterial vs. fungal), detect natural vs lab-grown viruses, and perhaps distinguish a pathogen from a benign biological agent (i.e., threat potential). As new viruses emerge and localized outbreaks expand, lipidomics will accelerate our understanding of viral infections and aid in maximizing the discovery of novel biomarkers of pathogenicity and host response.